Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.
Alessandro Canella,Hector Cordero Nieves,Douglas W Sborov,Luciano Cascione,Hanna S Radomska,Emily Smith,Andrew Stiff,Jessica Consiglio,Enrico Caserta,Lara Rizzotto,Nicola Zanesi,Volinia Stefano,Balveen Kaur,Xiaokui Mo,John C Byrd,Yvonne A Efebera,Craig C Hofmeister,Flavia Pichiorri Oncotarget（2023）
关键词
myeloma cells,hdac,cd44 expression,inhibitor
AI 理解论文
溯源树
样例
